These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7498882)

  • 1. [Assessment of myocardial vitality with FDG-PET: still research or ready for general practice?].
    Schröter G; Schwaiger M
    Herz; 1995 Oct; 20(5):350-3. PubMed ID: 7498882
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical indications for PET of the heart].
    von Schulthess GK; Schwaiger M
    Schweiz Rundsch Med Prax; 1993 Aug; 82(34):914-8. PubMed ID: 8372296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Schelbert HR
    J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
    [No Abstract]   [Full Text] [Related]  

  • 5. Should 18F deoxyglucose scans be indicated for care of patients with coronary artery disease?
    Bianco JA; Wilson MA
    Cardiology; 1991; 79(3):219-26. PubMed ID: 1769037
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positron emission tomography: principles and uses in cardiology].
    Porenta G; Czernin J; Schelbert H
    Wien Med Wochenschr; 1992; 142(15-16):358-66. PubMed ID: 1481541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucose metabolism in myocardium and an assessment of myocardial viability by 18FDG-PET].
    Ogiu N; Nakai K; Hiramori K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):636-40. PubMed ID: 12436594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial glucose utilization in ischaemic heart disease: preliminary results with F18-fluorodeoxyglucose and positron emission tomography.
    Camici P; Araujo L; Spinks T; Lammertsma AA; Jones T; Maseri A
    Eur Heart J; 1986 Dec; 7 Suppl C():19-23. PubMed ID: 3493137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accumulation of fluorodeoxyglucose in ischemic myocardium. I. Comparison with myocardial perfusion at rest and during exercise].
    Yonekura Y; Senda M; Koide H; Saji H; Yamamoto K; Nishizawa S; Torizuka K; Fudo T; Hashimoto T; Kambara H
    Kaku Igaku; 1986 Oct; 23(10):1361-7. PubMed ID: 3493371
    [No Abstract]   [Full Text] [Related]  

  • 16. Positron emission tomography in human myocardial ischemia.
    Schelbert HR; Schwaiger M
    Herz; 1987 Feb; 12(1):22-40. PubMed ID: 3493961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of positron emission tomography (PET) in cardiologic diagnosis].
    Henze E
    Internist (Berl); 1990 May; 31(5):338-40. PubMed ID: 2380010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
    Schelbert HR
    Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
    [No Abstract]   [Full Text] [Related]  

  • 20. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.